BioSpace News Archive

Business

R1 RCM Reports Third Quarter 2019 Results

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, announced results for the three months ended September 30, 2019.

November 5, 2019
·
12 min read
Business

Surgery Partners, Inc. Announces Third Quarter 2019 Results

Surgery Partners, Inc., a leading short-stay surgical facility owner and operator, announced results for the third quarter ended September 30, 2019.

November 5, 2019
·
9 min read
Business

Blueprint Medicines Outlines Precision Therapy Research Vision, Provides Update on Discovery and Clinical-Stage Portfolio at R&D Day and Reports Third Quarter 2019 Financial Results

R&D Day presentation discloses four research programs demonstrating the transformative science, urgency and efficiency underpinning the company’s integrated precision medicine platform

November 5, 2019
·
13 min read
Rexall encourages all eligible Canadians to protect themselves by getting their flu shot, as the country braces for flu season

Cold and flu season is here, and Rexall is encouraging Canadians to keep their wellness a priority by getting their flu shots, which can help protect them from influenza, a potentially life-threatening infection.

November 5, 2019
·
2 min read
Business

Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform

Ongoing Phase 1/2a Study of CD19 CAR-NK with Pivotal Study Expected to Enroll Patients in 2021

November 5, 2019
·
9 min read
Business

Novanta Announces Financial Results for the Third Quarter 2019

Third Quarter 2019 GAAP Net Income of $8.9 million

November 5, 2019
·
28 min read
Business

Gossamer Bio to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 12, 2019

In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Tuesday, November 12, 2019 to discuss the Company’s financial results and provide a corporate update.

November 5, 2019
·
1 min read
Deals

Axovant Gene Therapies Announces Investor Conference Presentations for the Remainder of 2019

Axovant Gene Therapies, Ltd., a clinical-stage company developing innovative gene therapies, announced that Pavan Cheruvu, M.D., chief executive officer, will present at the following investor conferences

November 5, 2019
·
4 min read
Business

Allergan Reports Third Quarter 2019 Financial Results

Allergan plc reported its third quarter 2019 financial results including GAAP net revenues of $4.05 billion, a 3.6 percent increase from the prior year quarter.

November 5, 2019
·
16 min read
IMBiotechnologies Ltd. Expands Approval for EkobiTM Embolization Microspheres to Include Treatment of Uterine Fibroids

EkobiTM Embolization Microspheres, a novel embolization medical device has received Health Canada approval for the treatment of uterine fibroids, a significant women’s health issue.

November 5, 2019
·
3 min read